Cargando…
Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease
The use of non-steroidal anti-inflammatory drugs (NSAIDs) is widespread worldwide thanks to their analgesic, anti-inflammatory and antipyretic effects. However, even more attention is placed upon the recurrence of digestive system complications in the course of their use. Recent data suggests that t...
Autores principales: | Utzeri, Erika, Usai, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473116/ https://www.ncbi.nlm.nih.gov/pubmed/28652650 http://dx.doi.org/10.3748/wjg.v23.i22.3954 |
Ejemplares similares
-
Gut Microbiome and Intestinal Permeability Are Promising Targets for Treating Nonalcoholic Fatty Liver Disease
por: Heshmati, Hassan Massoud
Publicado: (2021) -
Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Yang, Meng, et al.
Publicado: (2021) -
Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis
por: De Munck, Toon J. I., et al.
Publicado: (2020) -
The Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: Association of Intestinal Permeability with Disease Severity and Treatment Outcomes
por: Zhuang, Yu-Pei, et al.
Publicado: (2022) -
The Gut Microbiota, Intestinal Permeability, Bacterial Translocation, and Nonalcoholic Fatty Liver Disease: What Comes First?
por: Spengler, Erin, et al.
Publicado: (2015)